Navigation Links
FDAnews announces Biopharmaceutical Good Distribution Practices Summit
Date:1/24/2013

harma (invited)
  • Mark Seitz , Global Logistics Advisor/Director, Eli Lilly(invited)
  • Sally Wong , Stability Manager, Eli Lilly (invited)
  • Tim Valko , Executive Director, Operations Risk Management, Amgen (invited)
  • Register Today

    Combining a mix of presentations and panel discussions — featuring regulators and industry experts — this Summit has something for everyone.  Each presenter and panelist will be providing a few "take-away" solutions.  After three days, you'll leave with 50 solutions, tips and tricks to take back to your company.  Anticipated Summit sessions include:

    • Developing a Controlled-Environment Logistics Validation Master Plan
    • Cubist Pharmaceutical Case Study:  Managing a Virtual Supply Chain
    • FDA's Perspective on GDP:  Harness and Harmonize Your Operations and Quality Teams
    • Without True Distribution Validation Integrity, You're in for a World of (Global) Hurt
    • Panel Discussion:  Strengthening the Distribution Chain — How to Protect Your Product from Crooked Employees, Pirates, Warehouse Warriors and Other Miscreants
    • Applying Proven Risk Management Controls to Stability Testing to Support Distribution of New Drug Products
    • Maybe the World Isn't Coming to an End, But It Sure Seems Like That on Some Days — Contingency Planning Best Practices for Biopharmaceutical GDPs
    • Panel Discussion: Good Distribution Practice Quality Agreements — Can't We Just All Get Along? Understanding Where Industry Has Consensus and Differences
    • Packaging As the First Line of Defense Against Counterfeiting

    Register now. You'll e
    '/>"/>

    SOURCE FDAnews
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
    2. FDAnews announces Third Annual Pharmaceutical Labeling Summit
    3. FDAnews Announces Medical Device Mobile Apps Virtual Conference
    4. FDAnews announces Fourth Annual Supplier Quality Congress
    5. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
    6. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
    7. BD Announces Webcast of Annual Meeting of Shareholders
    8. Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
    9. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
    10. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
    11. HemaTerra Announces New Quality Control Product For Blood Centers
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/1/2015)... 1, 2015  Research Solutions, Inc. (OTCQB: RSSS), a pioneer ... (STM) information for life science companies, academic institutions, and ... at the LD Micro Invitational being held on June ... Los Angeles . ... June 3rd at 9:30 a.m. Pacific time, with one-on-one ...
    (Date:6/1/2015)... June 1, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... public offering of its common stock consisting of 1,475,506 ... to be sold by certain of its stockholders. In ... option to purchase up to an additional 590,202 shares ...
    (Date:6/1/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... data from its Phase I/II clinical trial of  ... (GBM), the most common and deadly form of ...
    Breaking Medicine Technology:Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8
    ... DIEGO , April 27 CareFusion Corporation (NYSE: CFN ) ... Thursday, May 6 following the close of trading on the New York Stock ... The company will host a webcast and ... ( 5 p.m. Eastern time ) to discuss the results for its third quarter, ...
    ... , April 27 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... provide a general business overview, as well as to discuss first quarter 2010 ... Eastern Time ( 2:00 p.m. Pacific Time ).  Financial results for the ... day. , , , ...
    Cached Medicine Technology:CareFusion Will Host an Earnings Conference Call on May 6 to Discuss the Results for the Third Quarter of Fiscal 2010 2Onyx Pharmaceuticals Announces First Quarter 2010 Financial Results Teleconference and Webcast 2
    (Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... (NAPW) honors Kathy Everette-Gaines as a 2015-2016 inductee ... She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more ... Chapters. , “I’m pleased to welcome Kathy into ...
    (Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lenita F. Cornett, DSL, LSSBB (C), First Sergeant A ... VIP Woman of the Year Circle. She is recognized ... NAPW is the nation's leading networking organization exclusively for ... 200 operating Local Chapters. , “I'm pleased to recognize ...
    (Date:6/1/2015)... 01, 2015 Carson Energy also announced ... investors IRA transactions. AdvantaIRA Trust, LLC is the country’s ... ability to fund positions using IRA’s does 2 things:, ... a project, even if there current cash position will ... funding source for Carson and their investors to be ...
    (Date:6/1/2015)... York (PRWEB) June 01, 2015 The ... ) has amended the Case Management Order governing ... testosterone gel. The Amended Order which was issued ... on May 29, 2015, directs the parties to submit ... August 10, 2015 that outlines parameters and the process ...
    (Date:6/1/2015)... 2015 Atagi Plastic Surgery and Skin ... an Ultherapy® Ultra Treatment Provider by Ulthera, ... Aesthetics is one of only six practices in Colorado ... provider. , Atagi Plastic Surgery and Skin Aesthetics’ ... has led the practice to earn the distinction of ...
    Breaking Medicine News(10 mins):Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2
    ... By Amanda Gardner HealthDay Reporter , TUESDAY, ... belly fat of 10 heart attack patients managed to improve ... is the first time this type of therapy has been ... Tuesday at the American Heart Association,s annual meeting in Chicago. ...
    ... Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... advisers were weighing Tuesday whether to recommend the first ... the autoimmune disease lupus. The drug, belimumab (Benlysta), ... treat patients who suffer from systemic lupus erythematosus. ...
    ... study from the Swedish medical university Karolinska Institutet shows ... aneurysm. These drugs, which block cysteinyl-leukotrienes, could reduce the ... of the aortic wall, and thus the risk of ... the need for complicated and risky surgery. The results ...
    ... MONDAY, Nov. 15 (HealthDay News) -- It rarely happens, ... and sponges are left inside children undergoing surgery, according to ... mishaps were not more likely to die, but the errors ... long and cost more than double that of the average ...
    ... The risk of radiation-induced breast cancer from mammography screening ... saved, according to a new study appearing online and in ... "Recently, there have been reports in the press focusing on ... periodic screening," said the study,s lead author, Martin J. Yaffe, ...
    ... factor 7 (rFVIIa) a drug used to treat ... not recommended because of the potential for adverse events, ... Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100408.pdf. Recombinant activated factor ... of bleeding in hemophilia patients. It is also used ...
    Cached Medicine News:Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 2Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 3Health News:FDA Advisers Consider New Lupus Drug 2Health News:Aortic aneurysm treatable with asthma drugs 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 3Health News:Radiation fears should not deter women from mammography screening 2Health News:Hemostatic drug less effective than originally predicted 2
    The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
    ... DW4 liquid handling system from Molecular Devices ... in one instrument. The system handles a ... plate washing96-, 384- and 1536-welland is the ... DW4 has been optimized to dispense from ...
    ... washers available to handle multiple ... assays. Embla 384 Cell washer ... been optimized to avoid cell ... compatible and have been integrated ...
    Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
    Medicine Products: